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Natural Killer Cell Degeneration Exacerbates
Experimental Arthritis in Mice Via
Enhanced Interleukin-17 Production
Cherry Kam Chun Lo,1 Queenie Lai Kwan Lam,1 Lingyun Sun,2 Shengjun Wang,3
King-Hung Ko,1 Huaxi Xu,3 Chang-You Wu,4 Bo-Jian Zheng,1 and Liwei Lu1
Objective. An altered phenotype and dysfunction
of natural killer (NK) cells have been observed in
patients with rheumatoid arthritis. The aim of this
study was to determine whether dysregulated NK cells
contribute to the pathogenesis of experimental arthritis.
Methods. For initiation of collagen-induced ar-
thritis (CIA), DBA/1J mice were immunized with type II
collagen in Freund’s adjuvant. Control mice were im-
munized with adjuvant alone. NK cells from the blood,
spleens, and bone marrow of immunized mice were
analyzed by flow cytometry. Levels of interleukin-17
(IL-17) secretion and autoantibody production were
measured by enzyme-linked immunosorbent assays. Im-
munized mice in which NK cells were depleted by
anti–asialo GM1 antibody treatment were assessed for
the development of CIA. Moreover, sorting-purified NK
cells from both mice with CIA and control mice were
analyzed for cytokine gene expression.
Results. We observed markedly reduced frequen-
cies of NK cells in the blood and spleens of mice with
CIA compared with the frequencies in adjuvant-treated
control mice. Upon NK cell depletion, immunized mice
displayed an early onset of arthritis with more severe
clinical symptoms, which correlated with increased
plasma cell generation and autoantibody production.
Moreover, a substantially increased number of IL-17–
secreting cells in synovial tissue and more pronounced
joint damage were observed. Freshly isolated NK cells
from mice with CIA showed markedly reduced expres-
sion of interferon- (IFN). Furthermore, coculture of
normal NK cells and CD4 T cells revealed that NK
cells strongly suppressed production of Th17 cells via
their IFN production.
Conclusion. These results suggest that NK cells
play a protective role in the development of experimen-
tal arthritis, an effect that is possibly mediated by
suppressing Th17 cell generation via IFN production.
Natural killer (NK) cells are lymphocytes of the
innate immune system that play an important role in
eliminating virus-infected cells and tumor cells. In addi-
tion to their involvement in innate immunity, NK cells
can shape adaptive immunity by cytokine production
and direct killing of other immune cells. Increasing
evidence indicates a regulatory role of NK cells in
autoimmunity (1). The elimination of NK cells either
promotes or suppresses autoimmune diseases, suggest-
ing that NK cells exert divergent effects on the patho-
genesis of autoimmunity (2–9). For example, a protec-
tive role of NK cells has been reported in a CD4 T cell
transfer mouse model of colitis (6), in Freund’s complete
adjuvant–mediated protection against diabetes (7), and
in experimental autoimmune encephalomyelitis (5,9), in
which NK cells were shown to inhibit and kill autoreac-
tive T cells. In contrast, NK cells have been shown to
promote autoimmune diseases such as neonatal auto-
immune ovarian disease (2) and experimental auto-
immune myasthenia gravis (8) by inducing pathogenic T
cell responses. Furthermore, recent findings that NK
cells can eliminate activated macrophages (10) and
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dendritic cells (11) suggest that NK cells may act as an
immune regulator by modulating antigen-presenting
cells (APCs).
Rheumatoid arthritis (RA) is a chronic inflam-
matory disease characterized by joint inflammation that
leads to destruction of cartilage and bones. Although the
etiology of RA remains unclear, numerous studies on
the roles of T cells, NK T cells, Treg cells, B cells,
macrophages, and mast cells in the onset and progres-
sion of disease have been extensively performed (12–21).
However, much less is known about the role of NK cells
in the pathogenesis of autoimmune arthritis.
Dysfunction of NK cells was observed in patients
with systemic-onset juvenile RA (22), and NK cells in
synovial fluid from a patient with RA showed a unique
phenotype (23). However, whether NK cells play a role
in the development of autoimmune arthritis remains
largely unclear. Despite RA being recognized as a
Th1-mediated autoimmune disease in the past, previous
findings that interferon- (IFN) receptor–deficient
mice show increased susceptibility to collagen-induced
arthritis (CIA) support the notion that IFN suppresses
autoimmunity (24). It has become clear that the differ-
entiation of interleukin-17 (IL-17)–secreting Th cells
(Th17 cells) requires cytokines, including transforming
growth factor  (TGF), IL-6, IL-1, and IL-23 (25–27),
whereas IL-4 and IFN suppress IL-17 production
(28,29). CIA is markedly suppressed in IL-17–deficient
mice, demonstrating a crucial role of IL-17 in the
development of autoimmune arthritis (30,31). Recently,
it was shown that IFN regulates susceptibility to CIA in
mice through the suppression of IL-17 (32).
Although NK cells are among the major IFN-
producing cells in immune responses, it remains un-
known whether or not NK cells can possibly modulate
the development of Th17 cells via their production of
IFN. In the present study, we tested the hypothesis that
NK cell dysfunction augments experimental arthritis by
modulating Th17 cells via IFN production.
MATERIALS AND METHODS
Mice. Male DBA/1J mice were purchased from The
Jackson Laboratory (Bar Harbor, ME) and maintained in a
specific pathogen–free animal facility at the University of
Hong Kong. All animal experiments conducted in this study
were approved by the University Committee on the Use of
Live Animals in Teaching and Research. Mice ages 8–12 weeks
were used for the experiments.
Initiation of CIA. CIA was initiated as previously
described (33). Briefly, 100 g of bovine type II collagen
(Chondrex, Redmond, WA) dissolved in 0.1M acetic acid was
emulsified with an equal volume of Freund’s complete adju-
vant (2 mg/ml) (Difco, Detroit, MI) and administered intra-
dermally at the base of tail into DBA/1J mice. On day 21, a
booster emulsion prepared with type II collagen and Freund’s
incomplete adjuvant (Difco) was intradermally administered
near the primary injection site. Following the same protocol,
adjuvant-treated littermates that were given phosphate buff-
ered saline (PBS) in place of type II collagen served as
controls. Beginning on day 18, the mice were scored for
arthritis severity once every 2 days, as previously described
(33).
Preparation of cell suspensions from joint tissue.
After skin, muscle, and bone were removed under a dissecting
microscope, joint samples of the front paw were minced and
incubated with collagenase in RPMI 1640 at 37°C for 1 hour.
Cell suspensions were filtered through a cell strainer. After
lysis of red blood cells, the numbers of viable nucleated cells
were determined by trypan blue exclusion.
Flow cytometry and cell sorting. Surface staining was
performed using the following anti-mouse monoclonal anti-
bodies from BD Biosciences (San Jose, CA) and BioLegend
(San Diego, CA): fluorescein isothiocyanate (FITC)–
conjugated antibodies including annexin V, anti-CD49b (clone
DX5), anti-IgM (clone R6-60.2), anti-CD23 (clone B3B4),
anti-GL7 (clone Ly77), and anti-IFN (clone XMG1.2);
phycoerythrin-conjugated antibodies including anti-CD49b
(clone DX5), anti-CD3 (clone 145-2C11), anti-CD4 (clone
GK1.5), anti-CD21 (clone 7G6), anti-CD11c (clone N418),
and anti–IL-17 (clone TC11-18H10.1); Cy5-conjugated anti-
bodies including anti-CD3 (clone 145-2C11), anti-IgM (clone
R6-60.2), anti-B220 (clone RA3-652), and anti-CD4 (clone
GK1.5); and biotinylated anti-B220 (clone RA3-652). A min-
imum of 20,000 events per sample were collected (34). Splenic
DX5CD3 NK cells were sorted with an Epics Altra flow
cytometer (Beckman Coulter, Fullerton, CA), and the purity
was routinely 96%.
Cell cycle analysis. CD3 T cells were removed from
the spleen cells of both mice with CIA and control DBA/1J
mice, using magnetic microbead separation (Miltenyi Biotec,
Auburn, CA) before staining with FITC-conjugated anti-DX5
antibody, followed by fixation with cold 70% ethanol. Cells
were treated with 50 g/ml of RNase (Sigma-Aldrich, St.
Louis, MO) and 50 g/ml of propidium iodide (PI) (Sigma-
Aldrich) before flow cytometric analysis (34).
Proliferation assay. Sorted NK cells (2  105/well)
were seeded into a 96-well round-bottomed plate and pulsed
with IL-2 (2,000 IU/ml) for 3 days and 6 days (R&D Systems,
Minneapolis, MN). Tritium-labeled thymidine (3H-thymidine;
1 Ci/well) was added for the last 16 hours, and 3H-thymidine
incorporation was measured as previously described (35).
Cytotoxicity assay. The killing activity of NK cells was
examined by cytotoxicity assay using flow cytometric analysis
(36). Briefly, YAC-1 target cells were labeled with 2 M
carboxyfluorescein diacetate succinimidyl ester (Invitrogen,
Carlsbad, CA) and washed before being cultured with splenic
NK cells purified from mice with CIA and control mice, at
effector:target ratios of 5:1, 10:1, and 20:1 and incubated in the
presence of IL-2 in 5% CO2 at 37°C for 16 hours. Dead cells
were detected by staining with PI (10 g/ml) for 15 minutes.
Flow cytometric analysis was performed to assess NK lytic
activity, and cytotoxicity was calculated as follows: % cytotoxi-
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city  (specific lysis  spontaneous lysis)/(100% – spontane-
ous lysis)  100%.
Real-time quantitative reverse-transcriptase–
polymerase chain reaction (RT-PCR). Total RNA was ex-
tracted from sorting-purified DX5CD3 splenic NK cells
from mice with CIA and control mice or from the joints of
control IgG-treated and asialo GM1–treated mice with CIA,
using TRIzol reagent (Invitrogen). Samples of joint tissue were
prepared from the front paw after removing skin tissue and
bones under a dissecting microscope. The messenger RNA
(mRNA) levels of selected genes were determined using the
SYBR Green Two-Step qRT-PCR Kit with ROX (Invitrogen)
according to the manufacturer’s guidelines and as previously
described (37).
The sequences of gene-specific primers spanning an
intron are as follows: for IFN (181 bp), sense 5-
AAGCGTCATTGAATCACACC-3, antisense 5-CGAAT-
CAGCAGCGACTCCTT-3; for tumor necrosis factor 
(TNF) (196 bp), sense 5-TGGCCTCCCTCTCATCAG-3,
antisense 5-GGCTGGCACCACTAGTTG-3; for TGF (161
bp), sense 5-GCGGCAGCTGTACATTGA-3, antisense 5-
CCGGGTTGTGTTGGTTGT-3; for IL-10 (166 bp), sense
5-GGCCCAGAAATCAAGGAG-3, antisense 5-CCTTG-
TAGACACCTTGGT-3; for IL-13 (211 bp), sense 5-
GCCGGTGCCAAGATCTGT-3, antisense 5-GCCATG-
CAATATCCTCTG-3; for colony-stimulating factor 1
(CSF-1) (188 bp), sense 5- ATGGACACCTGAAGGTCCT-
G-3, antisense 5-GTTAGCATTGGGGGTGTTGT-3; for
IL-17A (196 bp), sense 5-AAAGCTCAGCGTGTCCAAAC-
3, antisense 5-TGAGCTTCCCAGATCACAGA-3.
The quantitative RT-PCR analysis was conducted with
an ABI Prism 7700 Sequence Detection System (Applied
Biosystems, Foster City, CA), and the cycling parameters were
as follows: 50°C for 2 minutes, 95°C for 10 minutes, followed by
40 cycles at 95°C for 15 seconds and 60°C for 1 minute. Data
were analyzed with Sequence Detection System software (Ap-
plied Biosystems), and the threshold cycle (Ct) value within the
log-linear range of the amplification curve was determined.
Relative expression was quantitated by the comparative Ct
method, in which fold differences were calculated with nor-
malization to actin and controls.
Coculture of CD4 cells with NK cells and intracell-
ular staining. DX5CD3 NK cells were purified from the
spleens of DBA/1J mice, using an NK Cell Isolation Kit
(Miltenyi Biotec) according to manufacturer’s instructions.
CD4 T cells were isolated from the spleens of DBA/1J by
CD4 (L3T4) microbeads (Miltenyi Biotec). Splenocytes from
which CD3 T cells were depleted by microbeads were used as
APCs. CD4 T cells (1  106/ml) were cultured with CD3/
CD28 T cell expander (1:5 dilution) (Invitrogen), recombinant
murine IL-6 (rMuIL-6) (20 ng/ml), rMuIL-23 (20 ng/ml), and
rMuTGF (2 ng/ml) (R&D Systems), as previously described
(3), in the presence or absence of NK cells (1  106/ml), with
or without anti-mouse IFN antibodies (10 g/ml) or anti-
mouse IL-4 antibodies (10 g/ml) (Peprotech, Rocky Hill, NJ)
for 3 days. For Th17 cell detection by flow cytometry, cells
were pulsed with phorbol myristate acetate (100 ng/ml), iono-
mycin (750 ng/ml) (Sigma-Aldrich), and GolgiPlug (1 g/ml)
(BD Biosciences) for the last 5 hours before surface staining
with anti-CD4 antibodies and intracellular staining with anti-
IFN and anti–IL-17 antibodies, using a Caltag intracellular
staining kit (Invitrogen).
NK cell depletion in vivo. To deplete NK cells in vivo,
mice were injected intraperitoneally with 50 g asialo GM1
antibody (Wako, Richmond, VA) in 500 l of PBS, 2 days
before the first immunization, followed by 8 injections, once
every 5 days (3). Control mice were treated with control
normal rabbit IgG (Upstate Biotechnology, Lake Placid, NY).
Histopathologic analysis. Joint tissue specimens were
fixed in 10% buffered formalin for 3 days, followed by decal-
cification in 15% formic acid overnight before being embedded
in paraffin. Tissue sections (4 m thick) were prepared for
hematoxylin and eosin staining. Histologic analyses were per-
formed as previously described (33).
ELISPot assay. The numbers of type II collagen–
specific antibody-secreting plasma cells and IL-17–producing
cells were determined by ELISPot assay. Briefly, 96-well
flat-bottomed filtration plates with a cellulose ester membrane
(Millipore, Billerica, MA) were coated with bovine type II
collagen (5 g/ml; Chondrex, Redmond, WA) or rat anti-
mouse IL-17 (2 g/ml; R&D systems) in coating buffer (0.05M
carbonate, pH 9.6) at 4°C overnight. Plates were washed with
washing buffer (0.05% Tween 20 in PBS) and then blocked
with 5% fetal calf serum at room temperature for 1 hour. Cells
were seeded into wells and incubated at 37°C for 4 hours and
24 hours for the detection of antibody-producing plasma cells
and IL-17–producing cells, respectively, before being washed.
To detect antibody-producing plasma cells, alkaline phospha-
tase (AP)–conjugated goat anti-mouse IgG (HL) (1:1,000
dilution; Invitrogen) was added, whereas for detection of
IL-17–producing cells, biotinylated goat anti-mouse IL-17 (200
ng/ml; R&D Systems) was added and incubated at room
temperature for 2 hours, followed by AP-conjugated strepta-
vidin (1:1,000 dilution; Invitrogen) at room temperature for 1
hour. Plates were washed and developed by adding BCIP/
nitroblue tetraziolium (Sigma-Aldrich).
Enzyme linked immunosorbent assay (ELISA). Serum
levels of total and type II collagen–specific IgG were measured
by a colorimetric sandwich ELISA, as previously described
(35). Goat anti-mouse IgG (Invitrogen) and bovine type II
collagen (Chondrex) were coated on 96-well MaxiSorp plates
(Nunc, Rochester, NY) at 5 g/ml in coating buffer at 4°C
overnight. Plates were washed before blocking with blocking
buffer (0.5% gelatin, 0.5% bovine serum albumin, and 0.05%
Tween 20 in PBS) at room temperature for 1 hour. Diluted
serum samples (1:500) were added and incubated at room
temperature for 1 hour. Plates were washed and incubated
with AP-conjugated goat anti-mouse IgG (HL) (1:1,000
dilution; Invitrogen) at room temperature for 1 hour. Plates
were washed again, 1 mg/ml of freshly prepared phosphatase
substrate (Sigma-Aldrich) in substrate buffer (0.1M diethyl-
amine buffer, pH 9.6) was added, and absorbance at 405 nm
was measured using a Sunrise microplate reader (Tecan,
Durham, NC). Levels of IL-17 in culture supernatant were
measured using a DuoSet ELISA Development Kit (R&D
Systems), following the manufacturer’s protocol.
Immunohistochemical staining. Paraffin sections of
joint tissue were rehydrated and treated with 15% hydrogen
peroxide. Samples were blocked with 10% rat serum and
incubated with biotinylated anti–IL-17 antibodies (BioLegend).
Brown precipitates were developed using StreptABComplex/
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HRP (Dako, High Wycombe, UK) and 3,3-diaminobenzidine
tetrahydrochloride solution (Sigma-Aldrich). The nucleus was
counterstained with Mayer’s hematoxylin.
Statistical analysis. Data are expressed as the mean 
SD. Statistical analysis was performed using unpaired 2-tailed
t-tests. P values less than 0.05 and less than 0.01 were consid-
ered significant.
RESULTS
Reduced frequencies of NK cells in the spleen
and peripheral blood of mice with CIA. To characterize
changes in NK cell populations during the pathogenesis
of experimental arthritis, both the frequency and abso-
lute number of NK cells were examined in various
lymphoid organs and the peripheral blood of mice with
CIA and control mice, by flow cytometry. The frequency
of DX5CD3 NK cells was moderately decreased in
the peripheral blood before the onset of arthritis symp-
toms, and this decrease usually occurred 1–3 days after
the second type II collagen immunization (data not
shown). Subsequently, the frequency of NK cells in the
spleen and peripheral blood became markedly reduced
in mice with CIA during the early stage of disease
development, i.e., 1–4 weeks after the second immuni-
zation (Figure 1A).
In contrast, an increased number of CD3 T
cells was detected during the initiation of CIA, which
was consistent with our previous findings (33). Although
the total number of nucleated cells was significantly
increased in the spleens of mice with CIA, the absolute
number of splenic NK cells was reduced to levels that
were 45% of control values (mean SD 2.0 0.3 106
versus 0.9  0.2  106; P  0.01) (Figure 1B). Similar
patterns of reduced NK frequencies were detected in the
peripheral blood and spleens of mice with CIA at the
chronic stage of disease, i.e., 12–16 weeks following the
second immunization with type II collagen (data not
shown). However, no obvious changes in the frequency
of NK cells was observed in the bone marrow (Figure
1B).
Increased apoptosis and reduced cytotoxicity of
splenic NK cells in mice with CIA. To determine
whether increased apoptosis contributed to the reduced
population of splenic NK cells in mice with CIA, we
evaluated spontaneous apoptosis of splenic NK cells in
short-term cultures, in which apoptotic cells accumulate
in the absence of phagocytosis (34). Flow cytometric
analysis detected a significantly higher incidence of
apoptosis of splenic NK cells in mice with CIA after 16
hours of culture (Figure 2A). To examine whether NK
cells from mice with CIA were defective in terms of cell
proliferation, cell cycle analysis was performed on
Figure 1. Reduced frequency and number of natural killer (NK) cells in
the spleens and peripheral blood of mice with collagen-induced arthritis
(CIA). A, Single-cell suspensions were prepared from the blood, spleens,
and bone marrow (BM) of type II collagen–immunized mice and
adjuvant-treated control (CTL) mice on day 30 after the first immuniza-
tion and stained with anti-DX5 and anti-CD3 antibodies for flow cyto-
metric analysis. Boxed areas show the populations of CD3DX5 NK
cells and CD3DX5 NK cells, with their frequencies indicated. The
results are representative of 10 mice per group. B, Total number of NK
cells from the spleens and bone marrow of mice with CIA and control
mice on day 30 after the first immunization. Values are the mean and SD
results from 5 independent experiments.   P  0.01.
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freshly prepared splenic NK cells from mice with CIA
and control mice, and no alterations in cell cycle pro-
gression were observed (Figure 2B).
To verify the NK cell proliferative capacity, pu-
rified splenic DX5CD3 NK cells from both mice
with CIA and control mice were cultured in the presence
of IL-2 for up to 6 days and assayed for 3H-thymidine
incorporation. NK cells from both mice with CIA and
control mice showed a normal proliferative capacity in
response to IL-2 stimulation (Figure 2C). We next
analyzed the cytotoxicity of purified NK cells as deter-
mined by their ability to lyse YAC-1 cells (36). Splenic
NK cells from mice with CIA displayed significantly
reduced cytotoxic function compared with control mice
(Figure 2D), indicating that diminished NK cells with
impaired cytotoxicity are associated with the develop-
ment of CIA.
Early onset of arthritis with significantly in-
creased disease severity and autoantibody production in
immunized mice with NK cell depletion. To evaluate the
role of NK cells in the development of autoimmune
arthritis, we depleted NK cells in type II collagen–
immunized mice by administering anti–asialo GM1 anti-
bodies once every 5 days, starting 2 days before the first
type II collagen immunization. The effectiveness of NK
cell depletion was verified by flow cytometry. Two days
after treatment with anti–asialo GM1 antibodies, the
frequency of DX5CD3 NK cells in peripheral blood
was markedly reduced (mean  SD 0.7  0.3% versus
4.1  0.5% in IgG-treated control mice), whereas the
Figure 2. Enhanced apoptosis and defective killing ability of splenic NK cells isolated from mice with CIA. All mice were
analyzed on day 30 after the first immunization. A, Splenocytes from mice with CIA and control mice were cultured in medium
for 16 hours. The percentages of annexin V–positive DX5CD3 NK cells were measured by flow cytometry. B, CD3
cell–depleted splenocytes were prepared from mice with CIA and control mice and gated on DX5 NK cells for cell cycle
analysis. Histograms are representative of 3 separate experiments, and the percentages of DX5 NK cells in the G0/G1 and
SG2/M phases are indicated. C, NK cells were purified from the spleens of mice with CIA and control mice and cultured with
interleukin-2 for 3 days and 6 days before 3H-thymidine was added for the last 16 hours. D, Splenic NK cells purified from mice
with CIA and control mice were analyzed for their cytotoxicity by incubating with 5,6-carboxyfluorescein succinimidyl
ester–labeled YAC-1 cells at the indicated effector:target (E:T) ratios. Flow cytometric analysis was performed to assess NK
cell cytotoxicity. Values in A, C, and D are the mean  SD results from 3 independent experiments. cpm  counts per minute;
PI  }}} (see Figure 1 for other definitions).   P  0.05.
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frequencies of DX5CD3 NK T cells remained un-
changed between these 2 groups (2.5  0.6% and 2.8 
0.4%, respectively), indicating that NK cells were spe-
cifically depleted by anti–asialo GM1 antibody treatment.
Upon depletion of NK cells in vivo, type II
collagen–immunized mice showed an earlier onset of
arthritis (almost 1 week earlier) as compared with
control normal rabbit IgG–treated mice (Figure 3A).
Almost 80% of mice in the anti–asialo GM1 antibody–
treated group developed arthritis 3 days after the
booster immunization, while only 5% of mice in the
control group showed clinical symptoms. Moreover, the
clinical scores for arthritis severity were markedly ele-
vated in NK cell–depleted mice at the acute stage of
CIA development (Figure 3B). Histopathologic analysis
also showed more pronounced synovial hyperplasia and
tissue damage in the joints of anti–asialo GM1 antibody–
treated mice, as revealed by elevated histopathologic
Figure 3. Effect of natural killer (NK) cell depletion in exacerbating the development of collagen-induced arthritis (CIA). NK cells were depleted
in vivo by intraperitoneal injection of anti–asialo GM1 antibodies 2 days before the first immunization, followed by 8 injections, once every 5 days.
Mice injected with normal rabbit IgG (control IgG) were used as controls. A, Percentage of immunized mice (n 20 in each group) in which arthritis
developed. B, Clinical scores for arthritis severity as assessed in anti–asialo GM1 antibody– and control IgG-treated mice (n  20 in each group).
C, Hematoxylin and eosin–stained sections of inflamed joints from anti–asialo GM1 antibody– and control IgG-treated mice on day 40 after the first
immunization. D, Histopathologic scores for joint tissue from anti–asialo GM1 antibody– and control IgG-treated mice on day 40 after the first
immunization. Values are the mean and SD results from 10 mice per group.   P  0.05;   P  0.01.
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scores for synovial inflammation, cartilage damage, and
bone erosion (Figures 3C and D). These data strongly
indicate the involvement of NK cells in the development
of arthritis.
Consistent with augmented inflammatory re-
sponses in NK cell–depleted mice with CIA, the total
numbers of nucleated cells in spleen and joint tissue
were substantially increased in anti–asialo GM1
antibody–treated mice (Figure 4A). In addition, the
numbers of follicular B cells and germinal center B cells
were significantly increased after depletion of NK cells
(Figure 4B). Serum levels of anti–type II collagen–
specific IgG were significantly elevated, together with a
marked increase in the number of type II collagen–
specific IgG-producing plasma cells in bone marrow,
spleen, and joint tissue from NK cell–depleted mice with
CIA (Figures 4C and D). These results indicate that NK
cell depletion enhances plasma cell generation and
autoantibody production during the development of
CIA.
Figure 4. Enhanced type II collagen–specific autoantibody production and increased number of plasma cells in NK
cell–depleted mice with CIA. All mice were analyzed on day 30 after the first immunization. A, Total number of cells in bone
marrow (BM), spleen, and joint tissue from anti–asialo GM1 antibody– and control IgG-treated mice with CIA. B, Analysis of
immune cell populations in the spleens of anti–asialo GM1 antibody– and IgG-treated mice with CIA. The total numbers of T1
(B220CD23IgMhighCD21low), T2 (B220CD23IgMhighCD21high), marginal zone (MZ; B220CD23IgMhighCD21high),
follicular (FB; B220CD23IgMlowCD21low), and germinal center (GC; GL7B220) B cells, as well as Th cells (CD4),
cytotoxic T cells (CD8), macrophages (Mac-1), and dendritic cells (CD11c) were enumerated. C, Serum levels of total and
type II collagen (CII)–specific autoantibodies in NK cell–depleted mice with CIA and control mice as measured by
enzyme-linked immunosorbent assay. D, Type II collagen–specific IgG-producing plasma cells in bone marrow, spleen, and joint
tissue from NK cell–depleted mice with CIA and control mice as measured by ELISPot assays. Values are the mean and SD
results from 3 independent experiments. OD405  optical density at 405 nm (see Figure 3 for other definitions).   P  0.05;
  P  0.01.
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Increased IL-17–secreting cells in draining
lymph nodes and joints of NK cell–depleted mice with
CIA. Recent studies have shown that Th17 cells are
indispensable for the development of autoimmune ar-
thritis. To determine the effect of NK cell depletion on
IL-17 production in vivo, we found that the number of
IL-17–secreting cells was significantly increased in the
draining lymph nodes and joint tissue of anti–asialo GM1
antibody–treated mice with CIA, as detected by
ELISPot analysis (Figure 5A), indicating a role of NK
cells in IL-17 induction within local joint tissue and
lymph nodes. In addition, levels of secreted IL-17 in
culture supernatants of lymph node cells increased	2.5-
fold in the NK cell–depleted group (Figure 5B). Real-
time PCR analysis revealed dramatically increased levels
of IL-17 mRNA expression in joint tissue from NK
cell–depleted mice with CIA; this finding was further
supported by immunohistochemical detection of abun-
dant IL-17–secreting cells in the joint tissue (Figures 5C
and D). Taken together, these findings provide strong
Figure 5. Elevated numbers of interleukin-17 (IL-17)–secreting cells in draining lymph nodes (LNs) and joints from natural killer (NK)
cell–depleted mice with collagen-induced arthritis (CIA). All mice were analyzed on day 30 after the first immunization. A, ELISPot analysis for
IL-17–secreting cells in spleens, draining lymph nodes, and inflamed joints of anti–asialo GM1 antibody– and control IgG-treated mice with CIA.
Results are representative of 3 independent experiments. B, IL-17 levels in the supernatant of cultured spleen and lymph node cells isolated from
anti–asialo GM1 antibody– and control IgG-treated CIA mice as analyzed by enzyme-linked immunosorbent assay. Results are representative of 3
independent experiments. C, IL-17 mRNA expression in inflamed joint tissue from anti–asialo GM1 antibody– and control IgG-treated mice with
CIA as determined by real-time polymerase chain reaction analysis. Relative mRNA expression levels were normalized to actin. Results are
representative of triplicate samples in 2 independent experiments. D, Immunohistochemical staining of IL-17–producing cells in paraffin sections of
inflamed joint tissue from anti–asialo GM1 antibody– and control IgG-treated mice with CIA. Photomicrographs are representative of 4 independent
experiments. Values in A–C are the mean and SD.   P  0.01.
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evidence that NK cells might play a role in modulating
IL-17 production during the development of CIA.
Suppressed Th17 cell generation by NK cells
through IFN. The development of Th17 cells is largely
controlled by the cytokine milieu in the microenviron-
ment. NK cells are known to play a role in regulating
immune responses by producing both Th1 and Th2
cytokines. To examine possible changes in the cytokine
profile in NK cells during autoimmune conditions, we
used quantitative PCR analysis to measure mRNA levels
of IFN, TNF, TGF, IL-10, IL-13, and CSF-1 in
splenic DX5CD3 NK cells from mice with CIA and
control mice. The IFN mRNA level was significantly
reduced (by 4-fold), whereas IL-10 transcripts were
markedly up-regulated (by almost 5-fold) (Figure 6A).
To further confirm these data, we used flow cytometry to
examine the frequency of IFN-producing DX5CD3
NK cells. As shown in Figure 6B, the frequency of
Figure 6. Natural killer (NK) cell–mediated suppression of the generation of Th17 cells via interferon- (IFN) production. A,
Messenger RNA levels of IFN, tumor necrosis factor  (TNF), transforming growth factor  (TGF), interleukin-10 (IL-10), IL-13,
and colony-stimulating factor 1 (CSF-1) normalized to actin as determined in DX5CD3 NK cells isolated from the spleens of mice
with CIA and control mice by real-time polymerase chain reaction. Results are representative of triplicate samples in 3 independent
experiments. B, Percentages of CD3DX5IFN and CD3DX5IFN cells. Splenocytes from mice with CIA and control mice
were prepared for intracellular staining of IFN and gated on CD3 cells. Results are representative of 2 independent experiments.
C, Frequency of CD4IL-17IFN Th17 cells in the presence of NK cells. CD4 T cells from mice with CIA were cultured with
gamma-irradiated antigen-presenting cells, T cell expander (1:5 dilution), IL-6 (20 ng/ml), IL-23 (20 ng/ml), and TGF (2 ng/ml) with
or without NK cells isolated from adjuvant-treated mice. Intracellular staining of IL-17 and IFN was performed and analyzed on the
CD4 T cells. Results are representative of 3 independent experiments. D, Participation of IFN in suppressing the generation of
Th17 cells by NK cells. Purified splenic CD4 T cells were cultured for 3 days as described in C, but with or without the addition of
anti-IFN (10 g/ml) or anti–IL-4 (10 g/ml). IL-17–secreting cells were detected by ELISPot assay. Results are representative of 3
independent experiments. Values in A and D are the mean and SD.   P  0.05;   P  0.01.
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IFN-producing NK cells was markedly reduced by
3-fold in the spleens of mice with CIA. Previous
studies have demonstrated that IFN actively suppresses
the generation of Th17 cells (38) and plays a critical role
in the pathogenesis of CIA through the suppression of
Th17 cell development (32).
Because NK cells are known to be one of the
major and earliest sources for IFN production in
immune responses (39,40), our findings suggest a link of
defective IFN production by NK cells to unrestrain
Th17 cell generation during the pathogenesis of arthritis.
In order to verify this, we analyzed whether or not NK
cells can directly regulate Th17 cell generation. We
cultured CD4 T cells with NK cells prepared from
adjuvant-treated mice and analyzed the frequency of
Th17 cells. As shown in Figure 6C, flow cytometric
analysis detected a markedly reduced frequency of
CD4IL-17IFN Th17 cells in the presence of NK
cells, indicating that NK cells can inhibit the generation
of Th17 cells. The addition of blocking antibodies for
IFN reversed the inhibitory effects of NK cells on IL-17
production, suggesting that IFN participates in sup-
pressing the generation of Th17 cells by NK cells (Figure
6D). Taken together with the markedly reduced IFN
production in NK cells from mice with CIA, our data
support the notion that NK cells modulate the develop-
ment of Th17 cells under conditions of autoimmunity.
DISCUSSION
In this study, we observed substantially reduced
frequencies of NK cells in the peripheral blood and
spleens of mice with CIA. Splenic NK cells displayed
increased apoptosis with reduced cytotoxicity in arthritic
mice. Moreover, depletion of NK cells in vivo acceler-
ated the onset of disease and enhanced the clinical
severity of arthritis in type II collagen–immunized mice,
together with markedly increased autoantibody and
IL-17 production. NK cells isolated from mice with CIA
expressed low levels of IFN. We further showed that
IFN mediates the suppressive effect of NK cells on the
generation of Th17 cells. These results suggest that NK
cells play a protective role in the development of exper-
imental arthritis, possibly by modulating IL-17 produc-
tion via their IFN production.
Early studies have shown the recruitment of NK
cells into the target organs of patients with autoimmune
diseases including RA (41,42), suggesting the involve-
ment of NK cells in the pathogenesis of autoimmunity.
However, it is largely unclear how dysregulated NK cells
contribute to the development of experimental arthritis.
We observed that the degeneration of NK cells with
defective killing capacity is associated with the onset of
CIA, indicating that both numeric and functional
changes of NK cells may contribute to the pathogenesis
of CIA. Consistently, deficiencies in the number and
function of gut NK cells have been found to precede the
onset of diabetes in diabetes-prone BB rats, while NK
cell depletion abrogates cyclophosphamide-induced di-
abetes in NOD mice (3,4). A compromised killing ability
of NK cells in mice with CIA might facilitate the
formation of autoreactive T cells and APCs in inciting
experimental arthritis (5,43). Previous studies have indi-
cated that IL-10 provides a protective effect on the
development of arthritis (14,44). Although we detected
up-regulated IL-10 expression in splenic NK cells from
mice with CIA, a reduced number of NK cells might
minimize IL-10–mediated production.
Our data show that NK cells display elevated
apoptosis during the development of CIA. It has been
reported that the degeneration of NK cells in experi-
mental autoimmune myasthenia gravis is mediated by
IL-21 derived from autoreactive CD4 T cells (45).
However, we observed normal levels of IL-21 expression
in the CD4 T cells of mice with CIA (data not shown).
It currently remains unclear whether other cytokines
such as TNF are involved in mediating increased
apoptosis of NK cells (46). Further studies are war-
ranted to identify the triggering factors responsible for
enhanced NK cell apoptosis during CIA development.
The divergent functions of NK cells in the patho-
genesis of autoimmunity are mainly dependent on the
types of autoimmune diseases and animal models. Our
data indicate that NK cells may play a role in regulating
autoantibody-producing plasma cells during the patho-
genesis of CIA. Increased numbers of follicular and
germinal center B cells in the spleens of NK cell–
depleted mice with CIA indicate that more mature B
cells are activated, undergoing further differentiation
into antibody-producing plasma cells. The regulatory
mechanisms by which NK cells modulate adaptive im-
mune response are less well understood, but several
studies have suggested an important role for NK cells in
inhibiting T cell activation and in modulating the sur-
vival and function of dendritic cells (11). In addition, NK
cells have been shown to determine the outcome of B
cell–mediated autoimmunity (8). Consistent with previ-
ous observations that anti-DNA autoantibody produc-
tion correlated with the disappearance of NK cells in
autoimmunity-prone lpr mice (47), our findings suggest
that NK cells can either directly or indirectly affect B cell
maturation and antibody production in vivo. Further
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studies are being performed in our laboratory to eluci-
date the underlying mechanisms by which NK cells
modulate plasma cell generation and antibody secretion.
Increasing evidence highlights the critical roles of
cytokine secretion by and the killing ability of NK cells in
autoimmune diseases (43,48,49). In accordance with the
function of IFN as a potent inhibitor for Th17 cell
generation, our results that NK cells from arthritic mice
display reduced expression of IFN are consistent with
the findings of increased IL-17 production and exacer-
bated arthritis upon NK cell depletion in vivo. Our data
that NK cells suppress the generation of Th17 cells in
vitro, an effect that could be reversed by blockade of
IFN, provide strong evidence for a previously unrecog-
nized role of NK cells in inhibiting Th17 cell generation
via IFN. Although the possibility of reduced IFN
production by CD4 cells cannot be excluded (Figure
6B), it has been recently reported that CpG-induced
dendritic cell–NK cell interactions inhibit the effector
phase of inflammatory arthritis in the K/BxN mouse
serum transfer model, while IFN produced mainly by
NK cells blocks neutrophil recruitment to the joint (50).
Thus, IFN produced by NK cells may protect mice
from developing arthritis via diverse mechanisms. Taken
together, our findings demonstrate that NK cell degen-
eration promotes the onset and progression of experi-
mental arthritis, possibly through enhanced IL-17 pro-
duction. Therefore, functional modulation of NK cells
may provide a new therapeutic possibility for patients
with RA.
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